Vitreous proteomic analysis of proliferative vitreoretinopathy

被引:64
作者
Yu, Jing
Liu, Feng [2 ]
Cui, Shu-Jian [2 ]
Liu, Yan
Song, Zheng-Yu
Cao, Hui
Chen, Feng-E
Wang, Wei-Jun
Sun, Tao
Wang, Fang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Ophthalmol, People Hosp 1, Shanghai 200030, Peoples R China
[2] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China
关键词
biomarker; liquid chromatography; proliferative vitreoretinopathy; vitreous;
D O I
10.1002/pmic.200700824
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proliferative vitreoretinopathy (PVR) is the most common cause of anatomic failure in retinal detachment surgery. To understand the molecular mechanisms, vitreous proteomes of patients with PVR were investigated by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Vitreous samples of moderate PVR (grade B), and severe PVR (grade C or D) were aspirated during pars plana vitrectomy before infusion. In the current study, 129, 97 and 137 proteins were identified in vitreous of normal control, moderate and severe PVR, respectively. In PVR vitreous samples, complement components, serine proteinase inhibitors, and extracellular proteins were up-regulated or appeared, while normal cytoskeleton and metabolism proteins were down-regulated or disappeared. It was noteworthy that the proteins involved in transcription and translation regulation increased in vitreous with PVR. Among 102 PVR-specific proteins, kininogen 1 was specifically detected in both vitreous and the corresponding serum. Therefore, it can be concluded that PVR is a complicated pathology process with great amount of proteins involved in metabolism dysfunction, immune reactions, and cytoskeleton remolding. Kininogen 1 may be a candidate biomarker of PVR. Further investigations of these special proteins will provide additional targets for treatment or prevention of ocular proliferative diseases.
引用
收藏
页码:3667 / 3678
页数:12
相关论文
共 42 条
[1]   Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial [J].
Asaria, RHY ;
Kon, CH ;
Bunce, C ;
Charteris, DG ;
Wong, D ;
Khaw, PT ;
Aylward, GW .
OPHTHALMOLOGY, 2001, 108 (07) :1179-1183
[2]   IMMUNOHISTOLOGIC STUDY OF EPIRETINAL MEMBRANES IN PROLIFERATIVE VITREORETINOPATHY [J].
BAUDOUIN, C ;
FREDJREYGROBELLET, D ;
GORDON, WC ;
BAUDOUIN, F ;
PEYMAN, G ;
LAPALUS, P ;
GASTAUD, P ;
BAZAN, NG .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 110 (06) :593-598
[3]   Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders [J].
Cassidy, L ;
Barry, P ;
Shaw, C ;
Duffy, J ;
Kennedy, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (02) :181-185
[4]   Kallikrein-kinin in stroke, cardiovascular and renal disease [J].
Chao, J ;
Chao, L .
EXPERIMENTAL PHYSIOLOGY, 2005, 90 (03) :291-298
[5]   The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction [J].
Chao, Julie ;
Bledsoe, Grant ;
Yin, Hang ;
Chao, Lee .
BIOLOGICAL CHEMISTRY, 2006, 387 (06) :665-675
[6]  
CHARTERIS DG, 1992, OPHTHALMOLOGY, V99, P1364
[7]  
Devani M, 2002, AM J GASTROENTEROL, V97, P2026
[8]  
Diamandis EP, 2002, CANCER RES, V62, P295
[9]   Quantitative mass spectrometry identifies insulin signaling targets in C-elegans [J].
Dong, Meng-Qiu ;
Venable, John D. ;
Au, Nora ;
Xu, Tao ;
Park, Sung Kyu ;
Cociorva, Daniel ;
Johnson, Jeffrey R. ;
Dillin, Andrew ;
Yates, John R., III .
SCIENCE, 2007, 317 (5838) :660-663
[10]   A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis [J].
Espinola, RG ;
Uknis, A ;
Sainz, IM ;
Isordia-Salas, I ;
Pixley, R ;
DeLa Cadena, R ;
Long, W ;
Agelan, A ;
Gaughan, J ;
Adam, A ;
Colman, RW .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (03) :969-976